Additionally, BKT140, inhibited primary tumor growth and metastasis of head and neck cancer, and showed a CXCR4-dependent preferential cytotoxicity towards malignant cells of hematopoietic origin in multiple myeloma [126]. The gene discussed is CXCR4; the disease is neoplasm.